INTERVIEW: The Health Department has paused the rollout of the Oxford/AstraZaneca vaccine after studies showed it was not effective against the 501Y.V2 variant in the country. We’re now joined on the line by Professor Mosa Moshabela who is the UKZN Acting Deputy Vice-Chancellor for Research & Innovation.